Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 14, 2014
Total Value: $7.096B (75.7% shares, 24.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Pharmacyclics Inc. | 8,719,218 | $922M | 13.0% | $79.47 | — | COM | 716933106 |
| — | Seattle Genetics Inc. | 20,735,926 | $827M | 11.7% | $32.03 | — | COM | 812578102 |
| INCY | Incyte Corp. | 14,810,559 | $750M | 10.6% | $21.85 | +99.1% | COM | 45337C102 |
| — | Synageva Biopharma Corp. | 10,273,182 | $665M | 9.4% | $44.17 | — | COM | 87159A103 |
| ACAD | Acadia Pharmaceuticals Inc. | 19,955,126 | $499M | 7.0% | $13.77 | +71.3% | COM | 004225108 |
| — | Salix 2.75% 5/15/15 | 219,440,000 | $432M | 6.1% | $1.52 | — | CONV BONDS | 795435AC0 |
| — | Genomic Health Inc. | 13,650,835 | $400M | 5.6% | $31.71 | — | COM | 37244C101 |
| — | Incyte Genomics Notes 1.25% 11/15/2020 144A | 274,500,000 | $333M | 4.7% | $1.21 | — | CONV BONDS | 45337CAL6 |
| — | Incyte Genomics Notes 0.375% 11/15/2018 144A | 259,000,000 | $310M | 4.4% | $1.20 | — | CONV BONDS | 45337CAK8 |
| — | Incyte Genomics Notes 4.75% 10/1/2015 144A | 40,446,000 | $233M | 3.3% | $2.55 | — | CONV BONDS | 45337CAH5 |
| — | Xoma Corp. | 23,032,372 | $155M | 2.2% | $3.73 | — | COM | 98419J107 |
| BMRN | Biomarin Pharmaceuticals | 1,941,304 | $137M | 1.9% | $65.65 | +3.4% | COM | 09061G101 |
| — | Auxilium 1.5% 7/15/2018 | 87,090,000 | $96.34M | 1.4% | $0.96 | — | CONV BONDS | 05334DAA5 |
| HALO | Halozyme Therapeutics Inc. | 6,297,026 | $94.39M | 1.3% | $6.50 | +97.9% | COM | 40637H109 |
| — | Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | 22,898,000 | $79.37M | 1.1% | $2.76 | — | CONV BONDS | 09061GAD3 |
| — | Gilead 1.625% 5/1/16 | 21,500,000 | $70.91M | 1.0% | $2.26 | — | CONV BONDS | 375558AP8 |
| VNDA | Vanda Pharmaceuticals, Inc. | 4,791,179 | $59.46M | 0.8% | $7.41 | +36.1% | COM | 921659108 |
| — | Medivation 2.625% 4/1/17 | 39,500,000 | $57.81M | 0.8% | $1.27 | — | CONV BONDS | 58501NAA9 |
| — | Intermune Inc Notes 2.5% 12/15/17 | 41,000,000 | $56.16M | 0.8% | $1.07 | — | CONV BONDS | 45884XAF0 |
| CERS | Cerus | 8,455,306 | $54.54M | 0.8% | $4.84 | +29.8% | COM | 157085101 |
| BCRX | Biocryst Pharmaceuticals Inc. | 6,699,979 | $50.92M | 0.7% | $2.29 | +176.2% | COM | 09058V103 |
| — | Repros Therapeutics | 2,778,654 | $50.85M | 0.7% | $18.45 | — | COM | 76028H209 |
| — | Questcor Pharmaceuticals, Inc. | 775,864 | $42.25M | 0.6% | $51.83 | — | COM | 74835Y101 |
| — | Anacor Pharmaceuticals | 2,500,000 | $41.95M | 0.6% | $16.78 | — | COM | 032420101 |
| GILD | Gilead Sciences Inc. | 556,108 | $41.76M | 0.6% | $36.21 | +33.6% | COM | 375558103 |
| — | Mirati Therapeutics Inc. | 2,380,074 | $39.58M | 0.6% | $15.40 | — | COM | 60468T105 |
| — | Aegerion Pharmaceuticals | 500,000 | $35.48M | 0.5% | $63.34 | — | COM | 00767E102 |
| — | Arrowhead Research Corp. | 3,090,000 | $33.53M | 0.5% | $5.69 | — | COM | 042797209 |
| — | Clovis Oncology | 530,738 | $31.99M | 0.5% | $64.09 | — | COM | 189464100 |
| — | Derma Sciences | 2,558,857 | $27.69M | 0.4% | $12.90 | — | COM | 249827502 |
| — | Chelsea Therapeutics | 5,794,753 | $25.7M | 0.4% | $2.42 | — | COM | 163428105 |
| — | Medivation Inc. | 398,331 | $25.42M | 0.4% | $49.20 | — | COM | 58501N101 |
| — | Intercept Pharmaceuticals, Inc. | 362,847 | $24.77M | 0.3% | $44.84 | — | COM | 45845P108 |
| — | Progenics Pharmaceuticals, Inc. | 4,200,000 | $22.39M | 0.3% | $4.46 | — | COM | 743187106 |
| — | Salix 1.5% 3/15/19 | 15,000,000 | $22.37M | 0.3% | $1.49 | — | CONV BONDS | 795435AE6 |
| — | Intermune Inc Notes 5% 3/1/15 | 16,860,000 | $19.53M | 0.3% | $1.05 | — | CONV BONDS | 45884XAD5 |
| — | Avanir Pharmaceuticals | 5,428,591 | $18.24M | 0.3% | $4.31 | — | COM Class A | 05348P401 |
| — | Dyax Corp. | 2,026,537 | $15.27M | 0.2% | $7.54 | — | COM | 26746E103 |
| — | Idera Pharmaceuticals Inc. | 3,171,765 | $14.69M | 0.2% | $0.91 | — | COM | 45168K306 |
| — | Synergy Pharmaceuticals | 2,608,271 | $14.69M | 0.2% | $4.32 | — | COM | 871639308 |
| INSM | Insmed Inc. | 796,378 | $13.54M | 0.2% | $10.61 | +44.3% | COM | 457669307 |
| — | Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | 12,500,000 | $13.26M | 0.2% | $1.06 | — | CONV BONDS | 09061GAE1 |
| — | Stemline Therapeutics Inc. | 675,042 | $13.23M | 0.2% | $23.84 | — | COM | 85858C107 |
| — | Kythera Biopharmaceuticals | 313,191 | $11.7M | 0.2% | $34.55 | — | COM | 501570105 |
| — | Isis Pharmaceuticals | 247,036 | $9.842M | 0.1% | $26.87 | — | COM | 464330109 |
| — | Zogenix, Inc. | 2,751,000 | $9.463M | 0.1% | $2.18 | — | COM | 98978L105 |
| PRTA | Prothena Corp. PLC | 336,918 | $8.935M | 0.1% | $9.30 | +169.6% | SHS | G72800108 |
| — | Infinity Pharmaceuticals Inc. | 643,256 | $8.883M | 0.1% | $13.81 | — | COM | 45665303 |
| — | Threshold Pharma | 1,852,399 | $8.651M | 0.1% | $4.65 | — | COM | 885807206 |
| TGTX | TG Therapeutics | 2,199,656 | $8.579M | 0.1% | $4.61 | -12.3% | COM | 88322Q108 |
| — | QLT, Inc. | 1,535,863 | $8.555M | 0.1% | $4.39 | — | COM | 746927102 |
| — | Discovery Laboratories Inc. | 3,718,617 | $8.367M | 0.1% | $1.95 | — | COM | 254668403 |
| — | Array Biopharma Inc. | 1,500,000 | $7.515M | 0.1% | $4.54 | — | COM | 04269X105 |
| — | Ambit Biosciences Corp. | 747,954 | $7.21M | 0.1% | $7.00 | — | COM | 02318X100 |
| OMER | Omeros Corp | 608,404 | $6.869M | 0.1% | $5.96 | +61.8% | COM | 682143102 |
| — | Novavax | 1,286,913 | $6.589M | 0.1% | $3.15 | — | COM | 670002104 |
| IRWD | Ironwood Pharmaceuticals | 546,160 | $6.341M | 0.1% | $11.63 | -22.8% | COM | 46333X108 |
| — | Osiris Therapeutics Inc. | 375,282 | $6.035M | 0.1% | $16.64 | — | COM | 68827R108 |
| — | Xenoport | 1,034,112 | $5.946M | 0.1% | $4.95 | — | COM | 98411C100 |
| SGMO | Sangamo | 424,308 | $5.894M | 0.1% | $10.86 | +6.1% | COM | 800677106 |
| — | Portola Pharmaceuticals, Inc. | 224,434 | $5.779M | 0.1% | $24.57 | — | COM | 737010108 |
| — | Aerie Pharmaceuticals | 300,000 | $5.388M | 0.1% | $17.96 | — | COM | 00771V108 |
| XNCR | Xencor | 550,000 | $5.027M | 0.1% | $8.58 | 0.0% | COM | 98401F105 |
| — | BioDelivery Sciences Intl. Inc. | 846,005 | $4.983M | 0.1% | $4.06 | — | COM | 09060J106 |
| AGIO | Agios Pharmaceuticals | 205,750 | $4.928M | 0.1% | $27.47 | -17.0% | COM | 00847X104 |
| — | Biota Pharmaceuticals | 1,130,113 | $4.735M | 0.1% | $4.19 | — | COM | 090694100 |
| — | Ventrus Biosciences, Inc. | 1,215,840 | $4.645M | 0.1% | $2.40 | — | COM | 922822101 |
| — | Epizyme Inc. | 220,000 | $4.576M | 0.1% | $21.47 | — | COM | 29428V104 |
| — | Tekmire Pharmaceuticals Corp. | 500,000 | $3.985M | 0.1% | $7.97 | — | COM | 87911B209 |
| — | GW Pharmaceuticals PLC | 94,172 | $3.912M | 0.1% | $41.54 | — | ADS | 36197T103 |
| — | Ligand Pharmaceuticals Inc. | 73,400 | $3.861M | 0.1% | $37.40 | — | CLASS B | 53220K207 |
| — | Ophthotech Corp. | 103,040 | $3.333M | 0.0% | $32.35 | — | COM | 683745103 |
| ENTA | Enanta Pharmaceuticals | 109,097 | $2.976M | 0.0% | $19.50 | +24.3% | COM | 29251M106 |
| — | Receptos Inc. | 100,000 | $2.899M | 0.0% | $19.89 | — | COM | 756207106 |
| MGNX | Macrogenics | 100,000 | $2.743M | 0.0% | $26.16 | 0.0% | COM | 556099109 |
| — | Synta Pharmaceuticals | 500,000 | $2.62M | 0.0% | $4.99 | — | COM | 87162T206 |
| PBYI | Puma Biotechnology | 25,000 | $2.588M | 0.0% | $38.36 | +53.0% | COM | 74587V107 |
| — | Bluebird Bio Inc. | 114,461 | $2.401M | 0.0% | $26.81 | — | COM | 09609G100 |
| UTHR | United Therapeutics Corp. | 20,000 | $2.262M | 0.0% | $73.09 | +23.4% | COM | 91307C102 |
| — | Intermune Inc. | 150,000 | $2.21M | 0.0% | $14.73 | — | COM | 45884X103 |
| GERN | Geron Corp. | 402,629 | $1.908M | 0.0% | $1.08 | +295.4% | COM | 374163103 |
| OSUR | Orasure Technologies Inc. | 243,467 | $1.531M | 0.0% | $4.46 | +40.7% | COM | 68554V108 |
| — | Achillion | 455,000 | $1.51M | 0.0% | $8.18 | — | COM | 00448Q201 |
| — | Rigel Pharmaceuticals | 500,000 | $1.425M | 0.0% | $3.58 | — | COM | 766559603 |
| — | Karyopharm Therapeutics | 61,330 | $1.406M | 0.0% | $22.93 | — | COM | 48576U106 |
| FOLD | Amicus Therapeutics | 515,072 | $1.21M | 0.0% | $3.07 | -28.6% | COM | 03152W109 |
| — | Acceleron Pharma Inc. | 30,000 | $1.188M | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Ziopharm Oncology Inc. | 254,199 | $1.103M | 0.0% | $2.11 | — | COM | 98973P101 |
| — | Tesaro Inc. | 31,218 | $882K | 0.0% | $32.74 | — | COM | 881569107 |
| GALT | Galectin Therapeutics Inc. | 100,600 | $813K | 0.0% | $9.24 | 0.0% | COM | 363225202 |
| — | Foundation Medicine Inc. | 20,000 | $476K | 0.0% | $23.80 | — | COM | 350465100 |
| — | Five Prime Therapeutics Inc. | 19,823 | $333K | 0.0% | $16.80 | — | COM | 33830X104 |
| — | Salix Pharmaceuticals, Inc. | 3,621 | $326K | 0.0% | $66.16 | — | COM | 795435106 |
| — | Chemocentryx Inc. | 50,000 | $290K | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | 20,979 | $193K | 0.0% | $7.20 | — | PFD CONV EX | 23254L207 |